These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1134 related items for PubMed ID: 30235452

  • 1. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ, Wei CH, Chen YL, Cheng CY, Wang CL, Huang WC.
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [Abstract] [Full Text] [Related]

  • 2. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
    Liou CJ, Lee YK, Ting NC, Chen YL, Shen SC, Wu SJ, Huang WC.
    Cells; 2019 May 11; 8(5):. PubMed ID: 31083505
    [Abstract] [Full Text] [Related]

  • 3. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 4. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

  • 5. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway.
    Liou CJ, Dai YW, Wang CL, Fang LW, Huang WC.
    FASEB J; 2019 Nov 14; 33(11):11791-11803. PubMed ID: 31361524
    [Abstract] [Full Text] [Related]

  • 6. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M.
    J Hepatol; 2014 May 14; 60(5):1017-25. PubMed ID: 24362075
    [Abstract] [Full Text] [Related]

  • 7. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X, Liu Z, Wang J.
    Phytomedicine; 2023 Oct 14; 119():155005. PubMed ID: 37562090
    [Abstract] [Full Text] [Related]

  • 8. Tomatidine ameliorates obesity-induced nonalcoholic fatty liver disease in mice.
    Wu SJ, Huang WC, Yu MC, Chen YL, Shen SC, Yeh KW, Liou CJ.
    J Nutr Biochem; 2021 May 14; 91():108602. PubMed ID: 33548473
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF, Wang XN, Huang CC, Hu L, Xiao YF, Guan XH, Qian YS, Deng KY, Xin HB.
    Lipids Health Dis; 2017 Apr 27; 16(1):82. PubMed ID: 28449683
    [Abstract] [Full Text] [Related]

  • 10. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway.
    Yao H, Tao X, Xu L, Qi Y, Yin L, Han X, Xu Y, Zheng L, Peng J.
    Pharmacol Res; 2018 May 27; 131():51-60. PubMed ID: 29574225
    [Abstract] [Full Text] [Related]

  • 11. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ, Kim YM, Kim HJ, Jang SY, Oh MH, Lee DH, Chang KC.
    Eur J Pharmacol; 2016 Oct 05; 788():200-209. PubMed ID: 27343380
    [Abstract] [Full Text] [Related]

  • 12. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q, Sha S, Sun L, Zhang J, Dong M.
    Biochem Biophys Res Commun; 2016 Aug 05; 476(4):196-203. PubMed ID: 27208776
    [Abstract] [Full Text] [Related]

  • 13. Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway.
    Chang YH, Chen YL, Huang WC, Liou CJ.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):197-203. PubMed ID: 29113798
    [Abstract] [Full Text] [Related]

  • 14. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T, Park EJ, Je J, Jeong K, Yun SP, Kim HJ, Kim H, Park SW.
    Int J Mol Sci; 2021 May 24; 22(11):. PubMed ID: 34073834
    [Abstract] [Full Text] [Related]

  • 15. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
    Li Y, Liu Y, Chen Z, Tang K, Yang L, Jiang Y, Wang J, Huang P, Wang J, Zheng P, Song H.
    Biomed Pharmacother; 2023 Apr 24; 160():114319. PubMed ID: 36724639
    [Abstract] [Full Text] [Related]

  • 16. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y, Geng C, Liu X, Li M, Gao M, Liu X, Fang F, Chang Y.
    Mol Metab; 2017 Jan 24; 6(1):138-147. PubMed ID: 28123944
    [Abstract] [Full Text] [Related]

  • 17. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J, Du H, Shen M, Zhao Z, Ye X.
    J Immunol Res; 2020 Jan 24; 2020():3413186. PubMed ID: 32884949
    [Abstract] [Full Text] [Related]

  • 18. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.
    Liu Y, Li Y, Wang J, Yang L, Yu X, Huang P, Song H, Zheng P.
    BMC Complement Med Ther; 2022 Aug 09; 22(1):213. PubMed ID: 35945571
    [Abstract] [Full Text] [Related]

  • 19. Combination of luteolin and lycopene effectively protect against the "two-hit" in NAFLD through Sirt1/AMPK signal pathway.
    Zhu Y, Liu R, Shen Z, Cai G.
    Life Sci; 2020 Sep 01; 256():117990. PubMed ID: 32574665
    [Abstract] [Full Text] [Related]

  • 20. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR, Yang HJ, Park KI, Ma JY.
    Phytomedicine; 2019 Mar 01; 55():14-22. PubMed ID: 30668424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.